N53 ATI PHARM 207637583-Ati-Pharmacology.doc

  • Upload
    wmwrian

  • View
    271

  • Download
    0

Embed Size (px)

Citation preview

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    1/26

    treat HTN by blocking conversion of

    angiotensin I to angiotensin II

    ACE inhibitors (lisinoPRIL)

    treat HTN by blocking the binding of

    angiotensin II to recetors in tiss!es

    AR"# (lo#ARTAN)

    $lisinoPRIL ACE inhibitors

    $lo#ARTAN AR"#

    %hat to &onitor %hen taking ACE (lisinoPRIL)

    'AR"# ( lo#ARTAN)

    &onitor levels* blood ress!re and

    angiode&a (give ei s!b+)

    sto di!retics ,-$-. hrs before starting ACE inhibitors (lisinoPRIL)

    ACE (lisinoPRIL) &ay ca!se/ ersistent non rod!ctive co!gh

    side e0ects incl!de/ angiode&a (ad&inister ei

    s!b+) and hyotension $ sho!ld not be !sed in

    the ,nd'1rd tri&ester of regnancy

    ACE inhib(lisinoPRIL) ' AR"s (lo#ARTAN)

    AR" that sho!ld be taken 2 ho!r before &eals catoPRIL

    slo%s &ove&ent of calci!& into s&ooth

    &!scle cells ca!sing arterial dilation and

    decreased "P

    calci!& channel blockers (CC"s)

    a&lo3IPINE* veraa&il* cardi4e& CC"s

    !sed to treat angina and HTN CC"s/ a&lo3IPINE* veraa&il* cardi4e&

    &ay be !sed to treat a5b* a6!tter or #7T veraa&il and dilta4e&

    reca!tions'interactions in CC"s/ a&lo3IPINE*

    veraa&il* cardi4e&

    ts taking digo8in and beta$blockers9

    heart fail!re* heart block or bradycardia9

    do not cons!&e graefr!it :!ice

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    2/26

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    3/26

    barbit!ates or s!lfona&ides aldo&et)

    lactating &others sho!ld not !se these

    antihyertensives

    alha$, agonists (catares* tene8*

    aldo&et)

    dry &o!th* dro%siness'sedation* rebo!nd HTN*

    black'sore tong!e* le!koenia

    side e0ects of alha$, agonists (catares*

    tene8* aldo&et)

    ts sho!ld notify the hysician of this %hen

    taking alha$, agonists (catares* tene8*

    aldo&et)

    invol!ntary :erky &ove&ent* rolonged

    di44iness* rash* yello%ing of the skin

    decrease/ cardiac e8citability* cardiac o!t!t*

    and &yocardial o8ygen de&and9 lo%er "P by

    decrease release of renin in the kidney

    beta$blockers (&etor=L=L)

    beta$blockers (&etor=L=L) are

    contraindicated in ts %ith

    A7 block* or chronic resiratory diseases

    ;;;;;;; (beta$blocker) &ay &aks signs of

    hyoglyce&ia in diabetics

    roan=L=L

    do not ad&inister labet=L=L in the sa&e line

    %ith >

    f!rose&ide

    side e0ects of beta$blockers (&etor=L=L) bradycardia* nasal st!@ness* A7 block*

    bronchosas&

    hold beta$blockers (&etor=L=L) %hen #"P

    ;;;; or HR ;;;;;

    #"P 2BB ' HR B

    nitro* nicardIPINE* vasotec I7* es&olol are> vasodilators

    !sed in HTN e&ergencies b'c they directly

    dilate arteries and veins res!lting in decreased

    reload and afterload

    vasodilators (nitro* nicardIPINE* vasotec

    I7* es&olol)

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    4/26

    vasodilators (nitro* nicardIPINE* vasotec I7*

    es&olol) sho!ld not be !sed in ts %ith>

    heatic'renal disease* old age* electrolyte

    i&balances

    side e0ects of vasodilators (nitro* nicardIPINE*

    vasotec I7* es&olol)

    di44iness* HA* rofo!nd hyotension*

    cyanide to8icity*

    nitror!sside &ay not be &i8ed %ith ;;; any other &eds

    cardiac glycosides digo8in

    increases the force in velocity of heart

    contractions to i&rove stroke vol!&e (DB&L)

    and cardiac o!t!t and slo% cond!ction rate

    digo8in

    !sed to treat heart fail!re and a5b digo8in

    ;;;;;;;;; &eds increase risk of hyokale&ia

    and reciitate digo8in to8icity

    thia4ide' loo di!retics* AR"s

    (lo#ARTAN) 'ACE inhibitors (lisinoPRIL)

    signs of digo8in to8icity Early signs of to8icity/ FI !set/

    Anore8ia* N'7'3*

    Late signs of to8icity/ HA* vis!al

    dist!rbances* HR abnor&alities

    nor&al ser!& digo8in level BG. $ ,

    ad&inister ;;;; for digo8in overdose digibind

    in digo8in to8icity %hat sho!ld dysryhth&ias be

    treated %ith %hen digo8in is stoed

    dilantin

    slo%s cond!ction ti&e thro!gh the A7 node*interr!ts A7 node ath%ays to restore N#R

    adenosine

    rolongs reolari4ation* rela8es s&ooth

    &!scles* decreases vasc!lar resistance

    a&iodorone

    increases 5ring of the #A node and cond!ction atroine

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    5/26

    thro!gh the A7 node$ ooses action of the

    vag!s nerve

    convert s!raventric!lar tachycardia (#7T) to

    N#R

    adenosine

    treat 7$ib* !nstable ventriv!lar tachycardia a&iodarone

    treat asystole* bradycardia atroine

    anti$hyerliide&ia &eds statins

    ;;;; &ay ca!se rolonged bleeding in ts take

    co!&adin

    statins

    do not ad&inister statins %ith ;;;;;> graefr!it :!ice

    inhibits the absortion of cholesterol 4etia

    %hen sho!ld 4etia be taken 2 ho!rs before or - ho!rs after statins

    short$acting inhaler for ac!te bronchosas& alb!terol

    long acting inhaler for for long$ter& control of

    asth&a

    foradil* serevent

    oral* long acting beta$, adrenergic agonists

    (bronchodilator) !sed for long$ter& control of

    asth&a

    terb!taline

    ;;;;;; &eds that %ill increases the e0ect of

    bronchodilators

    ?A=Is

    ca!ses rela8ation of bronchial s&ooth &!scle

    ca!sing bronchodilation !sed for long ter&

    control of asth&a

    theoPHLLINE

    ;;;;;; and ;;;;;; decrease theoPHLLIN levels henobarbitol and henytoin

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    6/26

    therae!tic level of theoPHLLINE 2B$,B &cg'&L

    treat&ents of theoPHLLINE to8icity activated charcoal to decrease

    absortion* lidocaine for dysrhyth&ias

    and dia4ea& for sei4!res

    inhaled anticholinergics ca!sing

    bronchodilation

    iratr=PIJ?

    iratr=PIJ? is contraindicated in ts %ith a

    ;;;;;; allergy

    ean!t

    !se iratr=PIJ? %ith e8tre&e ca!tion in

    atients %ith ;;;;;; and ;;;;;;

    ac!te angle gla!co&e and "PH

    side e0ects of iratr=PIJ? dry &o!th'eyes and !rinary retention

    do not take gl!cocorticoids %ith ;;;;;;; N#AI3s

    revents e0ects of le!kotrienes ca!sing

    decreased/ in6a&&ation* bronchoconstriction*

    air%ay ede&a* and &!c!s rod!ction

    sing!lair* 4y6o

    ;;;;;;;; %ill decrease the circ!lating e0ects of

    sing!lar

    henobarbital

    side e0ects of sing!lair and 4y6o elevated LTs* %arfarin and theohylline

    to8icity

    slo%s carb absortion and digestion*

    contraindicated in ts %ith intestinal disease

    Precose* Flyset

    red!ces gl!coneogeneis* increases gl!cose!take by &!scles

    &etfor&in

    ro&otes release of ins!lin* lo%ers gl!cagon

    secretions and slo%s gastric e&tying

    Kan!via

    Kan!via dose sho!ld be red!ced in atients %ith i&aired renal f!nction

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    7/26

    diabetes &ed that sho!ld be %ithheld for -.

    hrs rior to and after contrast

    &etfor&in

    &etfor&in is contraindicated in atients %ith severe infection* shock* hyo8ic

    conditions

    red!ces rod!ction of gl!cose and sho!ld not

    be !sed %ith NPH

    randin* starli8

    ro&otes release of ins!lin fro& the ancreas glii4ide* glyb!ride

    these diabetes &eds ca!se high risk for

    hyoglyce&ia in ts %ith renal* heatic or

    adrenal disorders

    glii4ide* glyb!ride

    oral &edications that decreases ins!lin

    resistance

    Avandia* Actos

    oral diabetes &edications that have a high risk

    for CH d!e to 6!id retention

    Avandia* Actos

    onset of h!&alog less than 2 &in

    eak of h!&alog 1B$B &in

    d!ration of h!&alog 1$- ho!rs

    onsent of reg!lar ins!lin 1B$B &in

    eak of reg!lar ins!lin ,$1 ho!rs

    d!ration of reg!lar ins!lin $D ho!rs

    onset of NPH 2$, ho!rs

    eak of NPH -$2, ho!rs

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    8/26

    d!ration of NPH 2.$,- ho!rs

    onset of lant!s 2 ho!r

    eak of lant!s none

    d!ration of lant!s 2B$,- ho!rs

    3ra%ing$! reg!lar and NPH ins!lin N$R$R$N

    2G In:ect air into NPH

    ,G In:ect air into reg!lar

    1G 3ra% ! reg!lar ins!lin

    -G 3ra% ! NPH

    %hen sho!ld lant!s be ad&inistered at bedti&e

    do not &i8 other ins!lins %ith h!&alog* lant!s or co&bination ins!lins

    the only ins!lin given I7 reg!lar

    glyce&ic agent that breaksdo%n glycogen into

    gl!cose in the liver

    gl!cagon

    gl!cagon sho!ld not be &i8ed %ith ;;;;; and

    ;;;; sol!tions

    sodi!& or de8trose

    sti&!lates the &etabolis& of all body syste&s

    acclerating the rate of cell!lar o8ygenation

    synthroid

    side e0ects of synthroid' signs of

    hyerthyroidis&

    tachycardia* restlessness* diarrhea* %t

    loss* decrease bone density* heat

    intolerance* inso&nia

    inhibits synthesis of thyroid hor&one Taa4ole

    increases rod!ction of ins!lin$like gro%th

    factor

    so&at=TR=PIN

    avoid !se of ;;;;; %hen taking so&at=TR=PIN gl!ccocorticoids

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    9/26

    so&at=TR=PIN is ad&inistered s!b+

    ro&otes reabsortion of %ater %ith the

    kidneys9 vasocontriction of vasc!lar s&ooth

    &!scle

    des&oPRE##IN

    des&oPRE##IN is !sed to T8 diabetes insiid!s* cardiac arrest and

    noct!rnal en!resis

    side e0ects of des&oPRE##IN hyonatre&ia* sei4!res and co&a

    blood rod!ct !sed to relace vol!&e %hole blood (,$- hr)

    blood rod!ct !sed to T8 severe ane&ia*

    he&olytic ane&ia* erythroblastosis

    acked R"Cs (,$- hr)

    blood rod!ct to T8 active bleeding* alastic

    ane&ia* and bone &arro% s!oression

    latelets (2$1B &in)

    blood rod!ct !sed to T8 he&orrhage* b!rns*

    shock* TTP* and reverse e0ects of %arfain

    P

    sti&!lates R"C rod!ction Procrit

    sti&!lates M"C rod!ction &ay ca!se bone

    ain or le!kocytosis

    Ne!ogen* Ne!lasta

    sti&!lates latelet rod!ction Ne!&ega

    hold digo8in if an infants !lse is less than B

    hold digo8in if a childOs !lse is less than DB

    %hen to delay He " va8 allergy to bakerOs yeast* liver disease

    %hen to delay 3TaP va8 1B days after i&&!nos!ression

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    10/26

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    11/26

    %hen taking "actri& and #etra> cons!&e at least 1L of %ater* !se back$

    ! contracetives* avoid s!n e8os!re

    %hen taking tetraCCLINEs cons!&e at least 1L of %ater* !se back$

    ! contracetives* avoid s!n e8os!re

    do not give ;;;;;; to children less than . d!e to

    er&anent teeth discoloration

    tetraCCLINEs

    ;;;;;;;; ca!ses gingivitis* gingival hyerlasia 3ilantin

    %hat 7a8 are needed by age 3Ta* IP7* ??R* 7aricella*

    &onitor heatic'renal f!nction* refrigerate

    s!sensions* increased risk - bleeding in ts

    taking anticoag!lants

    3i6!can

    &onitor for dr!g ind!ced retinoathy in ts

    taking

    laS!enil* S!inine

    !sed for revention and T8 of T" INH* rifa&in

    recations %hen taking ;;;;;;; incl!de/

    risk of ne!roathies'heatoto8icity

    cons!&e "

    avoid alcholol

    INH

    avoid eating ;;;;; and taking ;;;;;; %hen on

    INH

    tyra&ine ' dilantin

    ;;;;;;;; %ill ca!se discoloration of !rine* saliva*s%eat and tears

    rifa&in

    ad&inister this antiretroviral on an e&ty

    sto&ach

    A

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    12/26

    %hen taking any antiretroviral

    2G>

    ,G>

    increase 6!id intake

    begin theray %ith 5rst onset of

    sy&to&s

    osteoorosis &eds (boniva* 4o&eta) absortion

    is decreased %hen taken %ithGGGGGG

    calci!&* =K* antacids* ca0eine

    osteoorosis &eds (boniva* 4o&eta) sho!ld be

    ad&inistered

    in the A? on an e&ty sto&ach

    this &ed !sed to T8 rhe!&atoid arthritis is

    contraindicated in regnancy* renal'liver fail!re*

    soriasis* blood disorders

    3?AR3s

    this &ed (3?AR3) !sed to T8 rhe!&atoid

    arthritis &ay ca!se increased risk for infection*

    bone &arro% s!ression* FI !lceration

    &ethotre8ate

    laS!enil &ay ca!se retinal da&age (blindness)

    go!t &ed that inhibits !rac acid rod!ction

    !sed to treat ACJTE go!t

    allo!rinol

    go!t &ed that inhibits rocesses to revent

    le!kocytes fro& invading :oints !sed to treat

    CHR=NIC go!t

    colchine

    go!t &eds are contraindicated in ts %ith>>>> renal* cardiac and FI dysf!nction

    avoid ;;;;; %hen taking &eds for go!t A#A

    na&e - antian8iety &eds lora

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    13/26

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    14/26

    instr!ct client to take ;;;;;;; antideressants in

    the A?

    ##RIs (aroETINE* le8aro* l!vo8* 4oloft)

    ;;;;;; and ;;;;; %ill increase lithi!& levels N#AI3s and A#A

    &onitor ser!& ;;;;; levels %hen taking lithi!& sodi!&

    therae!tic level of lithi!& BG- $ 2&ES'L

    therae!tic e0ects of lithi!& begin in ;;; to ;;;

    days

    D to 2-

    %hat is the lithi!& to8icity level>

    #8/ FI distress* &ental conf!sion* oor

    coordination* coarse tre&ors

    2G to ,/ &oderate to advanced

    %hat is the lithi!& to8icity level>

    #8/ ata8ia* conf!sion* increased dil!te !rine

    o!t!t* bl!rred vision* clonic &ove&ents*

    sei4!res* st!or* severe hyotension* and

    co&a* !l&onary co&lications &ay lead to

    death $ !se ;;;;;;; to increase rate of e8cretion

    ,/ severe $ &annitol

    ac!te dyskinesias and dystonic reactions*

    tardive dyskinesia* Parkinsonis&* akinesia*

    akathisia* and ne!roletic &alignant syndro&e

    are>>>

    e8trayra&idal e0ects of conventional

    (haldol* thora4ine* nacene) antisychotics

    a disorder res!lting in invol!ntary* reetitive

    body &ove&ents

    tardive dyskinesia

    Co&&on sy&to&s incl!de/

    3ecrease in facial e8ressions

    3i@c!lty starting and controlling &ove&ent

    Loss or %eakness of &ove&ent (aralysis)

    #oft voice

    #ti0ness of the tr!nk* ar&s* or legs

    Parkinsonis&

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    15/26

    Tre&or

    absence* overty* or loss of control of vol!ntary

    &!scle &ove&ents

    akinesia

    a disorder in %hich there is an !rge or need to

    &ove the legs to sto !nleasant sensations

    akathisia

    #y&to&s incl!de high fever* s%eating*

    !nstable blood ress!re* st!or* &!sc!lar

    rigidity* and a!tono&ic dysf!nctionG

    ne!roletic &alignant syndro&e

    #y&to&s occ!r %ithin &in!tes to ho!rs of

    taking (aroETINE* le8aro* l!vo8* 4oloft)* and

    &ay incl!de/

    Agitation or restlessness

    3iarrhea

    ast heart beat

    Hall!cinations

    Increased body te&erat!re

    Loss of coordination

    Na!sea

    =veractive re6e8es

    Raid changes in blood ress!re

    7o&iting

    serotonin syndro&e

    !sed to &aintain sobriety in T8 of alcoholis& antab!se

    do not give antab!se %ithin ;;;; days of

    drinking alcohol

    2- days

    &edications !sed to treat &ysasthenia gravis Prostg&in* ?ytelase* Tensilon

    do not ad&inister &yasthenia gravis &eds if

    systolic "P is belo%

    B

    " decreases the e0ects of this arkinsonOs

    &ed

    levodoa

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    16/26

    ;;;;;;; ca!ses increased e8cretion of digo8in*

    %arfarin* and =CP

    3ilantin

    therae!tic range for 3ilantin 2B$,B

    do not take Ti&otic %hen !sing CC"s and beta$blockers

    ;;;;;; oiod is contraindicated after biliary

    tract s!rgery

    &orhine

    ;;;;;;; oiod is contraindicated in clients %ith

    renal fail!re

    3e&erol

    therae!tic level of &agnesi!& s!lfate -$.

    act on !terine &!scle to sto contractions tocolytics (brethine* rocardia* &ag

    s!lfate)

    signs of &agnesi!& s!lfate to8icity 3eressed 3TR (dee tendon re6e8)

    $ Resiratory deression

    $ Co&a

    $ Cardiac arrest

    $ 3eathG

    if yo! s!sect &ag to8icity > ad&inister Calci!& Fl!conateG

    3ecreased a&&onia level i&rove&ent in ts %ith heatic

    encehaloathy

    ?!scle sas&s indicate hyo or

    hyercalcae&ia

    hyocalcae&ia

    #8 of hyo or hyer calce&iaLethargy* %eakness* fatig!e* conf!sion* %t loss*

    bone ain* cardiac dysrhyth&ias and kidney

    stone

    hyercalce&ia

    ;;;;;;;;%ill be elevated in bone or liver disease

    and is also raised by alcohol and heatoto8ic

    FFT

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    17/26

    dr!gs

    A 6atted T %ave is indicated of > hyokale&ia

    a&inoglycosides (genta?CIN* vanco?CIN)

    are ad&inistered I7 over ;;;;;;;; (ti&e)

    2 ho!r

    a vasoressor !sed in the T8 of shock and

    heart fail!reG

    increases cardiac o!t!t by increasing

    &yocardial contractility

    Ualso dilates renal blood vessels* %hich increase

    renal rof!sion leading to increased !rine

    o!t!t

    doa&ine

    therae!tic e0ect of doa&ine increased !rine o!t!t d!e to dilated

    renal blood vessles and increased renal

    erf!sion

    side e0ects of doa&ine increased !lse

    HTN

    dysrhyth&ias

    !sed to correct hyotension that is

    !nresonsive to adeS!ate 6!id vol!&e

    relace&ent or occ!rs as art of shock

    syndro&e ca!sed by bactere&ia* chronic

    cardiac deco&ensation* dr!g overdose* ?I*

    oen$heart s!rgery* renal fail!re* tra!&a* or

    other &a:or syste&ic illnesses9 to i&rove lo%

    cardiac o!t!t

    vasoressors (doa&ine)

    Mhere is Penicillin F ad&inistered> PCN F is very irritating and sho!ld be

    in:ected into a large &!scle (ventral

    gl!teal ' vast!s lateralis) !sing a ,,$,F 2

    $2 2',V needle and sho!ld be

    ad&inistered dee

    %hy is ?ag s!lfate is ad&inistered to re$ to revent sei4!res

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    18/26

    ecla&sia ts>

    the best evidence of therae!tic resonse to

    Plavi8 is

    absence of angina* neck':a% ain and

    absence of di@c!lty s%allo%ing

    ts %ith an allergy to PCNs &ay also have an

    allergy to this ab8 class

    CEPH'alosorins

    N#AI3s ;;;;;;; di!retic e0ects red!ce

    to8ic levels of ;;;;;;;; can ca!se

    diloia'do!ble vision* HA* and vertigoG #er!&

    sodi!& levels can be i&acted and !rine

    o!t!t decreased

    ?edication !sed for alcohol %ithdra% are Libri!&

    Elavil* is a antideressant* the side e0ects are =rthostatic hyotension* di44iness* get !

    Q &ove slo%ly* ?onitor "P* Q heart rate

    before* and 2 ho!r after ad&inistering* if

    decrease in heart rate* hold &eds Q notify

    3octorG

    Elavil* Theray Relief can take 2 to 1 %eeks* and ossibly

    , to 1 &onths for f!ll bene5tG

    Elavil* also e0ects Jrinary retention* dry &o!th* bl!rred

    vision* hotohobia* constiation*

    tachycardia

    Proranolol* as Inderal* is a "eta "locker 3o not sto ab!rtly* client sho!ld &onitor

    heart* and "lood Press!re daily* Treats*

    hyerthyroidis&* &igraine* and gla!co&a

    Proranolol* Inderal #ide E0ect "radycardia* !lse rate belo% B* hold

    &edication Q call 3octor* 3iabetics can

    &ask tachycardia* &onitor gl!cose to

    detect hyoglyce&ia* 3ecreased cardiac

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    19/26

    o!t!t signs* are shortness of breath*

    ede&a* fatig!e* =rthostatic hyotension*

    faintness* Avoid in client %ith asth&a

    Lisinoril* as Prinivil is a Ace Inhibitorfor "lood Press!re

    Treats* Hyotension* heart fail!re*&yocardial infraction* it decreases the left

    ventric!lar dysf!nction

    Lisinoril* side e0ects are Ca!ses a 3ry co!gh* sto &edsG* notify

    3octor*

    hyerkale&ia* &onitor otassi!&*

    e8ected range 1G to * Rash Q

    dysge!sia* as altered taste*

    Angioede&a is a s%ollen tong!e* and oral

    haryn8* side e0ects are treated %ith

    in:ection of Einehrine

    3ystonia #as& #!stained* invol!ntary &!scle

    contractions

    3antri!&* is a #keletal ?!scle Rela8ant Treats ?alignant hyerther&ia* sti0ness*

    and sas&s* can occ!r d!ring s!rgery

    %ith certain tyes of anesthesiaG

    Cehalosorin* is a "road setr!& bacterial

    &edG

    Treats Jrinary tract infection* ost

    oerative infection* Q elvic infection

    Iron s!le&ent Need to take %ith 7iti&in C* olike orange

    :!i8ce* to increase absortion* Avoid &ilk*

    Q calci!&* it interferes %ith absortion*

    !se a stra% it can stain teeth* ?ay ca!se

    black stools and constiation

    Nitroress is !sed to treat congestive heart fail!re*

    and life threatening high blood ress!re*

    as hyertensionG

    ?yasthenia Fravis* Treat&ent 3r!gs It e0ects the &!scles of the eyes* face*

    &o!th* throat* neckG Me &ay see facial

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    20/26

    drooing* dr!gs !sed are Neostig&ine* as

    rostig&ine

    3ilantin* adverse e0ects are Hyerlasia* as bleeding F!&s* RashG*

    and3ilantin #ide E0ect* is Hair loss

    3ilantin* 3r!g interaction %ith =ral contracetives* Co!&adin* and

    Fl!ccocorticordsG*

    3ilantin are !sed to control #ei4!res

    Ti&olol Is a beta blocker* that is !sed for

    treat&ent of gla!co&a*

    as I=P of the eyes

    Probenecid* interacts %ith Anti go!t &edications* it revents re

    absortion of !ric acid Fo!t* it also

    inhibits the secretion of enicillin

    Pinicillin Interacts %ith Asirin* and A&inoglycosides* %hen

    &i8ed in the sa&e I 7 sol!tion

    Co!&adin kno%n as %arfarin INR/ ,$1* a anticoag!lant* revention of

    blood clotsG

    ?eds that interact* %ith co!&adin are

    Hearin* 3ilantin* Q Aceta&inohen as

    tylenol* and Asirin

    Hearin* Thera!etic Range B to .B* inhibits the clotting rocessG*

    latelet !nder 2B*BBB* sto &edication

    Hearin* I 7 3ri LabG 7al!e ?onitor aPTT 2G to ,G* ad&inister slo%ly*

    no &ore than ,B&g er &in!te* and

    B&g er 2B &in!teG*

    3igo8in* a cardiac glycoside 7al!e are 2G to ,GB* ?onitor otassi!&

    levels*

    The dr!g Lasi8* interacts %ith digo8in* and

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    21/26

    increases to8icity

    3igo8in* #ide E0ects are Anore8ia* tachycardia* bradycardia* and

    heart block

    Ta&o8ifen* A Cancer dr!g* a =ral ?edication Estrogen Recetor "locker* #tos gro%th

    of "reast Cancer* #ide E0ect are*

    Endo&etrial Cancer* abnor&al bleedingG*

    Hyrecalce&ia* &ontior calci!& levelsG*

    P!l&onary E&bol!s* shortness of breath*

    and chest ainG

    entanyl* is a Narcotic Analgesic It is &ore otent than &orhine* yo!

    need a %ritten rescrition for& Physician

    Theohylline* 3r!g A bronchodilator to treat asth&a*

    bronchitis* e&hyse&a* %hich Interacts

    %ith ca0eine

    Cro&oly& #odi!&* as Intal Inhaler Is a anti in6a&&atory* a Long acting

    control of asth&a*

    Mait 2 &in!te after !se for activity* or

    e8os!re to allergen

    Alb!terol* is !sed for e8ercise ind!ced Asth&a Jse the Alb!terol inhaler 5rst9 then %ait

    abo!t &in!tes before !sing the steroid

    inhalerG* This allo%s the Alb!terol to oen

    ! yo!r air%ays* so the steroid can %ork

    betterG

    Antihesti&ine* as "enadryl Ca!ses sleeiness

    PTJ* Interacts %ith 3igo8in* ?ay increase gl!coside levels

    PTJ* side e0ects Hyothyroidis&* Meight gain*

    "radycardia* Anore8ia* cold intolerance*

    heatic to8icityG* agran!locytosis is RARE*

    b!t ca!se sore throat* Q fever

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    22/26

    Loid ibrates* for Cholesterol Test ?onitor "aseline Liver f!nction* Q Renal

    f!nction test

    "ihoshonates "oniva* adds calci!& to bones for

    osteoorosis* Take on e&ty sto&achG* sit!right for 1B &in!tes after takingG* No

    food* or calci!& s!le&ents %ithin an

    ho!r of taking &edicationG* Not for atient

    %ith hyocale&ia* it can ca!ses cardiac

    arrest

    ?ethotre8ate* a Rhe!&atoid Arthiritis ?ed*

    interact %ith

    N#AI3* Q #!lfona&ides* &ay ca!se

    To8icity* &onitor levels

    Rhe!&atoid Arthiritis* indings to Reort Patient sho!ld be tested for t!berc!losis

    5rst* and any active infection* or 6!

    Rhe!&atoid Arthiritis ?edG Adverse E0ects Are at risk for infection* fever* sore throat*

    fetal death* heatic 5brosis* and sho!ld

    &onitor liver f!nction

    Ergostat* ?edication Treats &igraines

    Ergostat* #ide E0ect are etal abortion* FI disco&fort* na!sea*

    vo&itingG*

    Ergotis&* are &!scle ainG* Paresthesias*

    cold 5ngers Q toes

    "yetta* is a 3iabetes ?ellit!s*

    They are re5lled in:ection en

    Mhich can ca!se Pancreatitis* and severe

    abdo&inal ain* sto &edication* and

    notify doctorG* It also ca!ses F I e0ectsG*

    "yetta needs in:ected 2 ho!r rior to

    &eals* NE7ER INKECT ATER ?EAL* store

    in refridgarator

    Antivirals* &edications treat HI7* heres* Heatitis "* C* In6!en4a A Q

    "*

    #lo%s do%n viral load* and allo%s the T

    cells levels to stay nor&alG* Alha

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    23/26

    interferons inhibit sread of vir!ses to

    ne% cells

    Rifa&in A treat&ent given to T" atients* it is

    taken in con:!nction %ith the other 5rstline &edication* This can ca!se =RANFE

    C=L=RE3 JRINE* and er&enant

    discoloration of soft contact lensesG

    Potassi!& Inf!sion Five no faster than 2B&ES er ho!r and*

    val!e level 1G to GB

    If there is a &edication error Check atients vital signs 5rst

    Che&o 3r!gs* contraindication are Liver* kidney* %o&en regnant* and

    atient that %ith i&&!nos!ression

    Fara&yci&* is a Antibiotic Protien synthesis #ide E0ect* hearing lossG* Interacts %ith

    &ilk* calci!&* anatcids* and iron

    s!le&entsG* take 2 ho!r before &eals

    on a e&ty sto&ach

    Levodoa* a Anti ParkinsonOs dr!g It is converted into doa&ine in the brain*

    %hich increases intraoc!lar ress!re* and

    is contraindicated in closed angle

    gla!co&a

    Ne!rologic 3r!gs* as 3ilantin kno%n as

    Phenytoin* interacts %ith

    ?A=Is* Co!&adin* =ral contracetives*

    CN# deressants* and graefr!it :!ice

    "lood Press!re ?eds* as 3e&erol* ?orhine* Q

    entanyl* adverse e0ects

    Are Resiratory deression* and

    hyotension

    Ca!tion of =lder atients ?edications e0ect older atients liver*

    renal* F I* blood

    Hearin* Adverse E0ects "r!ising* etichiae* bleeding* and

    Thro&bocytoenia* lo% latelet

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    24/26

    Hearin* in:ections are Fiven s!bc!taneo!s* , inches fro& the

    !&bilic!s* aly ress!re for 2 to ,

    &in!tes after in:ection* Hearin is a anti

    clotting s!bstance for&ed by tiss!e cells*

    esecially the liver9 a antirothro&bin

    "enadryl* is a Antihista&ine H 2 Recetor #ide E0ects are #leeiness* and dry

    &o!th

    "acteria Cell Mall ?edications Are in:ected I ? in the b!ttlock &!scle

    area* ca!tion %ith in:ecting arteries

    "2, 3e5ciency* #igns Are Ne!roathy* beefy tong!e* Patients

    need to adhere to Lab tests* and blood

    co!nt levels

    "2, 3e5ciency* Treat&ent Cyanocobala&in as cobala&in in:ection*

    Teach atient to eat green leafy

    vegetables

    "2, 3e5ciency* ca!ses Hyokale&ia* &onitor otassi!& levels*

    also ernicio!s ane&ia* gastric byass*

    acid s!ression* CrohnOs* tae%or&* and

    ile!& resection

    Antilie&ic* as Liitor* and*

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    25/26

    s!scetible ersons receive certain

    anesthetic dr!gsG

    ?alignant Hyerther&ia* is treated %ith 3antri!&

    antihychotic dr!gs* as Haldol* Thora4ine*

    #ide e0ects

    Are 3ystonia* sas&* neck sas&

    Che&o 3r!gs* Adverse E0ects Are Hair loss* na!sea* vo&iting*

    diarrehea* and lo% %hite blood cells

    3i!retics* as Lasi8* Q =s&itrol* #ide E0ects Are 3ehydration* and Hyokale&ia*

    ca!ses lo% otassi!&* &onitor

    otassi!&* if belo% 1G2 notify doctor

    Calci!& channel "lockers* as 7eraa&il*

    side E0ects

    Are ede&a* hyotension* do not drink

    graefr!it :!ice

    =s&ostic 3i!retics* as =s&itrol treats Red!ces the intracranial ress!re of the

    eye

    7ita&in is a antidote for Patient* on co!&adin* and e8erience

    bleeding

    Al4hei&ers taking 3onee4il #ide E0ect Is dysnea* ca!ses bronchconstrictionG*

    N!rse sho!ld notify doctor

    Libri!& ?edication Prevents deliri!& tre&ors

    etrorolac Q Toradol #ide E0ects Increase risk of bleedingG* check for

    bri!singG* Take %ith food

    "etaace ?edication Is !sed to decrease heart rate

    I&d!r #ho!ld be given* if atients blood

    ress!re is less than B

    Narcan Is taking to revent hyotensionG* To %ake

  • 8/11/2019 N53 ATI PHARM 207637583-Ati-Pharmacology.doc

    26/26

    ! atient

    Pilocar Is !sed to treat gla!co&a* the rest of the

    atients life